The Outcomes of Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules

Last updated: March 18, 2026
Sponsor: Chinese PLA General Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Thyroid Disease

Treatment

ultrasound-guided thermal ablation

Clinical Study ID

NCT06340945
S2023-761-01
  • Ages > 18
  • All Genders

Study Summary

  1. To evaluate the clinical outcomes of ultrasound-guided thermal ablationfor the treatment of benign thyroid nodules;

  2. To develop and validate a artificial intelligence model to predict the outcomes of ultrasound-guided thermal ablation in the treatment of benign thyroid nodules

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • [1]confirmation of benign nodule status on two separate fine- needle aspiration (FNA) or core-needle biopsy (CNB) [2]no suspicious malignant features on ultrasoundexamination [3]report of cosmetic and/ or symptomatic problems or concern of nodulesgrowing rapidly or malignant transformation [4]refusal or ineligibility for surgery [5]follow-up time ≥6months

Exclusion

Exclusion Criteria:

  1. follicular neoplasm or malignancy findings on biopsy

  2. nodules with benign result on biopsy had suspicious of malignancy in US, includingmarked hypoechoic, ill-defined margins, taller-than-wide shape ormicrocalcifications

  3. patients with cystic nodules

  4. patients with contra-lateral vocal cord par- alysis

  5. previous radiation to the head and neck

  6. ; follow- up time less than 6 months

Study Design

Total Participants: 1500
Treatment Group(s): 1
Primary Treatment: ultrasound-guided thermal ablation
Phase:
Study Start date:
April 01, 2024
Estimated Completion Date:
December 31, 2029

Connect with a study center

  • Chinese PLA General Hospital

    Beijing,
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.